Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor.

One of the prominent shortcomings of matrices for tissue engineering is their poor ability to support angiogenesis. We report here on experiments to enhance the angiogenic properties of collagen matrices. Our aim is to achieve this goal by covalently incorporating heparin into collagen matrices and by physically immobilizing angiogenic vascular endothelial growth factor (VEGF) to the heparin. The immobilization of heparin was performed with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and N-hydroxysuccinimide (NHS). Carboxyl groups on the heparin are activated to succinimidyl esters, which react with amino functions on the collagen to zero length cross-links. This modification leads--in addition to the incorporation of heparin--to gross changes in in vitro degradation behavior and water-binding capacity. As a first approach to testing angiogenic capabilities, endothelial cells were exposed to nonmodified and heparinized collagen matrices. This exposure leads to an increase in endothelial cell proliferation. The increase can be further enhanced by loading the (heparinized) collagen matrices with VEGF. Evaluation of the angiogenic potential of heparinized matrices was further investigated by exposing them to the chorioallantoic membrane of chicken embryos and to the subcutaneous tissue of rats. Both approaches show that heparinized matrices have substantially increased angiogenic potential. In particular, the loading of heparinized matrices with VEGF invokes a further increase in angiogenic potential. It is apparent that the physical binding of VEGF to heparin allows for a release that is beneficial to angiogenesis. By varying the heparin and EDC/NHS concentrations during the modification process and by varying the loading with VEGF, the angiogenic potential as well as the degradation behavior can be adapted to obtain matrices that fulfill specific angiogenic requirements in the field of tissue engineering.

[1]  H. Sung,et al.  Effects of heparin immobilization on the surface characteristics of a biological tissue fixed with a naturally occurring crosslinking agent (genipin): an in vitro study. , 2001, Biomaterials.

[2]  A A Poot,et al.  Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[3]  W. Friess,et al.  Collagen--biomaterial for drug delivery. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  J. Veerkamp,et al.  Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. , 2000, Biomaterials.

[5]  J. Hubbell,et al.  Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. , 2001, Microvascular research.

[6]  J. Feijen,et al.  Successive epoxy and carbodiimide cross-linking of dermal sheep collagen. , 1999, Biomaterials.

[7]  I. Yannas,et al.  Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. , 1982, Science.

[8]  J. Feijen,et al.  Endothelial Cell Seeding on Crosslinked Collagen: Effects of Crosslinking on Endothelial Cell Proliferation and Functional Parameters , 2000, Thrombosis and Haemostasis.

[9]  Anthony Atala,et al.  Principals of neovascularization for tissue engineering. , 2002, Molecular aspects of medicine.

[10]  J. Feijen,et al.  Design of a new type of coating for the controlled release of heparin , 1997 .

[11]  J. Feijen,et al.  In vivo biocompatibility of carbodiimide-crosslinked collagen matrices: Effects of crosslink density, heparin immobilization, and bFGF loading. , 2001, Journal of biomedical materials research.

[12]  Y. Ikada,et al.  Introduction of functional groups onto the surface of polyethylene for protein immobilization. , 1993, Biomaterials.

[13]  J. Veerkamp,et al.  Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. , 2000, Biomaterials.

[14]  D. Klee,et al.  The chorioallantoic membrane of the chick embryo as a simple model for the study of the angiogenic and inflammatory response to biomaterials , 2001, Journal of materials science. Materials in medicine.

[15]  Anthony Atala,et al.  Systems for therapeutic angiogenesis in tissue engineering , 2000, World Journal of Urology.

[16]  C. M. Ofner,et al.  The determination of epsilon-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzenesulfonic acid. , 1992, Analytical biochemistry.

[17]  J. Feijen,et al.  Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. , 2001, Biomaterials.

[18]  I. Yannas,et al.  Glycosaminoglycan inhibition of collagen induced platelet aggregation. , 1978, Thrombosis research.

[19]  I. Yannas,et al.  Design of an artificial skin. I. Basic design principles. , 1980, Journal of biomedical materials research.